The European Court of Justice handed generics firms a victory on Thursday when it ruled that UK doctors could legally be incentivized to prescribe cheaper drugs.
New anti-counterfeiting efforts moved closer to reality in Europe after a Swedish pilot study of a two-dimensional barcode technology impressed industry associations.
FDA official indicates companies manufacturing in some foreign countries may have to work harder for U.S. regulatory compliance.
Financings Of The Fortnight gives updates on on Almira, Biocartis, AiCuris and NPS Pharmaceuticals.
FDA approval of Provenge for prostate cancer could come May 1, opening the door for the launch of the first cancer immunotherapy.
